Marc Tessier-Lavigne's Net Worth

Marc Tessier-Lavigne's net worth is estimated to be at least $44,474,041.95 as of 12/23/2024. CoreStreet's estimation of Marc Tessier-Lavigne's net worth is based on their sale of stock and current holding of stock.

Marc Tessier-Lavigne is Director at Denali Therapeutics Inc. They have executed at least 19 trades of stock as per SEC Form 4 filings. Their most recent trade was for 20,000 units of DNLI stock on 11/23/2022. Their biggest sale was on 06/16/2020 when they sold 400,000 units of Denali Therapeutics Inc stock for $10,440,000.00. They typically trade 4 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $44,474,041.95
Most recent insider trade:
  • Nov. 23, 2022

Marc Tessier-Lavigne's Insider Trading History

Denali Therapeutics IncTitleAmountPriceTypeTotal Value
Nov. 23, 2022
Director20,000$30.48Sell$609,600.00
Nov. 1, 2022
Director8,748$30.20Sell$264,189.60
Sept. 28, 2022
Director20,000$30.82Sell$616,400.00
Aug. 23, 2022
Director20,000$31.61Sell$632,200.00
July 25, 2022
Director20,000$35.61Sell$712,200.00
March 23, 2022
Director20,000$33.83Sell$676,600.00
Dec. 30, 2021
Director20,047$45.36Sell$909,331.92
Dec. 28, 2021
Director10,980$44.37Sell$487,182.60
June 7, 2021
Director94,378$70.35Sell$6,639,492.30
May 24, 2021
Director8,806$60.02Sell$528,536.12
May 21, 2021
Director37,957$60.13Sell$2,282,354.41
April 1, 2021
Director50,000$56.62Sell$2,831,000.00
June 16, 2020
Director400,000$26.10Sell$10,440,000.00
Regeneron Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Oct. 3, 2022
Director3,612$718.00Sell$2,593,416.00
Sept. 30, 2022
Director3,428$698.00Sell$2,392,744.00
March 21, 2022
Director7,439$690.00Sell$5,132,910.00
March 16, 2022
Director4,361$675.00Sell$2,943,675.00
Dec. 9, 2021
Director3,784$665.00Sell$2,516,360.00
Feb. 26, 2015
Director3,000$421.95Sell$1,265,850.00